Choosing allergy medication for CKD requires careful consideration, as impaired kidney function affects how the body processes and eliminates drugs. Around 3 million people in the UK live with chronic kidney disease, many experiencing seasonal or perennial allergies that need safe, effective management. Second-generation antihistamines such as loratadine are often suitable, whilst first-generation options and decongestants warrant caution. Dose adjustments based on your eGFR and consultation with your GP or renal specialist are essential before starting any new treatment, including over-the-counter products, to avoid medication accumulation and adverse effects.

Understanding Allergies and Chronic Kidney Disease

Chronic kidney disease (CKD) affects around 3 million people in the UK, many of whom experience the same seasonal and perennial allergies as the general population. However, managing allergic symptoms becomes considerably more complex when kidney function is impaired, as the kidneys play a crucial role in eliminating most medications from the body.

Allergies occur when the immune system overreacts to normally harmless substances such as pollen, dust mites, pet dander, or certain foods. Common symptoms include sneezing, itchy or watery eyes, nasal congestion, skin rashes, and in severe cases, anaphylaxis. For people with CKD, the challenge lies in selecting treatments that effectively control these symptoms without placing additional strain on already compromised kidneys.

The kidneys filter waste products and excess substances from the blood, including medication metabolites. When kidney function declines—measured by estimated glomerular filtration rate (eGFR)—drugs and their breakdown products may accumulate to potentially harmful levels. This accumulation can cause adverse effects or interact with other medications commonly prescribed for CKD, such as antihypertensives, phosphate binders, or erythropoiesis-stimulating agents.

Understanding your CKD stage is essential before selecting any allergy medication. CKD is classified into five stages based on eGFR, ranging from stage 1 (mild kidney damage with normal function) to stage 5 (kidney failure requiring dialysis or transplantation). The choice and dosage of allergy medications must be tailored to your specific kidney function, making consultation with your GP or renal specialist vital before starting any new treatment, including over-the-counter antihistamines.

Sources: NICE NG203 Chronic kidney disease: assessment and management; NHS Chronic kidney disease overview; UK Kidney Association guidance.

Safe Allergy Medications for People with CKD

Several allergy medications can be used safely in people with CKD when appropriately selected and dosed. Second-generation antihistamines are generally preferred as first-line treatment for allergic rhinitis and urticaria (hives) due to their favourable safety profile and reduced sedating effects compared to older alternatives.

Loratadine (brand example: Clarityn) is often suitable for people with kidney disease. It undergoes extensive hepatic (liver) metabolism rather than renal excretion, meaning reduced kidney function has minimal impact on drug clearance. Standard dosing (10 mg once daily) typically requires no adjustment in renal impairment, though individual assessment remains important, particularly if you have liver disease. Loratadine effectively controls symptoms such as sneezing, rhinorrhoea (runny nose), and itching with minimal sedation.

Cetirizine (brand examples: Piriteze, Zirtek) is another commonly used second-generation antihistamine, though it requires more careful consideration in CKD. Approximately 60–70% of cetirizine is excreted unchanged by the kidneys, necessitating dose reduction in moderate to severe kidney impairment. According to UK product information, for patients with moderate renal impairment (creatinine clearance 30–49 mL/min), the dose should be reduced to 5 mg once daily. In severe renal impairment (creatinine clearance 10–29 mL/min), 5 mg every other day is recommended. Cetirizine is not effectively removed by haemodialysis. Your GP or pharmacist can provide specific guidance based on your current kidney function.

Fexofenadine (brand example: Telfast) represents another option. It is partially renally excreted, and UK product information advises considering a starting dose of 60 mg once daily in patients with renal impairment. Your healthcare professional will determine the appropriate dose for your individual circumstances.

Kidney-safe local therapies are valuable additions or alternatives. Intranasal corticosteroids such as fluticasone (Flixonase) or mometasone (Nasonex) are highly effective for allergic rhinitis and have minimal systemic absorption, making them generally safe across all CKD stages. They work locally in the nasal passages with negligible kidney involvement. Maximal benefit may take several days of regular use, and correct administration technique is essential. Intranasal antihistamines (e.g., azelastine) and ocular antihistamines or mast-cell stabilisers (e.g., sodium cromoglicate eye drops) provide targeted symptom relief without systemic medication burden and may be particularly useful for people with CKD.

Sources: EMC SmPC for loratadine, cetirizine, and fexofenadine; BNF antihistamines; NICE CKS Allergic rhinitis; NHS Hay fever page.

Antihistamines to Use with Caution in Kidney Disease

First-generation antihistamines should generally be avoided or used with extreme caution in people with CKD due to their significant side effect profile and potential for drug accumulation. These older medications, whilst effective for allergy symptoms, carry substantial risks that are amplified in kidney disease.

Chlorphenamine (Piriton) and promethazine (Phenergan) are first-generation antihistamines that cross the blood-brain barrier, causing pronounced sedation, confusion, and cognitive impairment. In CKD patients—particularly older adults—these central nervous system effects are intensified and prolonged due to reduced drug clearance. The sedation can increase fall risk, impair driving ability, and worsen quality of life. Additionally, these medications possess anticholinergic properties that may cause urinary retention, constipation, dry mouth, and blurred vision—effects that can be particularly problematic for people managing multiple chronic conditions. UK product information advises dose reduction or caution with chlorphenamine and promethazine in renal impairment; your pharmacist or GP can advise on appropriate dosing if these medicines are necessary.

Hydroxyzine requires particular caution. The MHRA has issued warnings regarding hydroxyzine and the risk of QT interval prolongation (a heart rhythm abnormality), particularly in patients with risk factors including cardiovascular disease, electrolyte disturbances, or concurrent use of other QT-prolonging medicines. Hydroxyzine is contraindicated in patients with known QT prolongation or significant risk factors. It should be used at the lowest effective dose and avoided in elderly patients where possible. If you have CKD and are considering or currently taking hydroxyzine, discuss this with your GP or renal specialist to ensure it remains appropriate for you.

Combination products containing antihistamines alongside decongestants (such as pseudoephedrine or phenylephrine) warrant particular caution. Decongestants can elevate blood pressure—a critical concern as hypertension is both a cause and consequence of CKD. Many people with kidney disease already take multiple antihypertensive medications, and adding decongestants may counteract their effects and worsen blood pressure control. Always check labels carefully, as many over-the-counter cold and allergy preparations contain these combinations. Speak to your pharmacist or GP before using decongestant-containing products if you have CKD, particularly if you also have high blood pressure.

Sources: MHRA Drug Safety Update (2015) Hydroxyzine – risk of QT interval prolongation; EMC SmPC for hydroxyzine, chlorphenamine, and promethazine; BNF; NHS guidance on decongestants and high blood pressure.

Adjusting Allergy Treatment for Reduced Kidney Function

Dose adjustment based on kidney function is fundamental to safe medication use in CKD. Your healthcare team will use your eGFR—calculated from serum creatinine, age, and sex using current UK race-neutral equations—to determine appropriate dosing. This value should be monitored regularly, as kidney function can fluctuate, particularly during acute illness, dehydration, or when starting new medications.

For patients requiring antihistamines with significant renal excretion, individualised dosing schedules may involve reducing the dose, extending the interval between doses, or both. For instance, someone with moderate renal impairment taking cetirizine would typically reduce from 10 mg daily to 5 mg daily, whilst someone with severe renal impairment might take 5 mg every 48 hours. These adjustments maintain therapeutic benefit whilst minimising accumulation and adverse effects. Always follow the specific dosing guidance in the product information or as advised by your healthcare professional, as different medicines have different renal dosing bands.

Non-pharmacological approaches should complement medication in managing allergies. Environmental control measures—such as using allergen-proof bedding covers, maintaining humidity below 50% to reduce dust mites, keeping windows closed during high pollen counts, and using HEPA air filters—can significantly reduce allergen exposure. Nasal saline irrigation helps clear allergens and mucus without systemic medication. For patients with CKD, these strategies are particularly valuable as they reduce reliance on medications.

Topical nasal decongestants (e.g., xylometazoline) should be limited to short courses, typically no more than 7 days, to avoid rebound congestion. Intranasal corticosteroids are preferred for longer-term nasal symptom control and do not carry this risk. Correct inhaler technique is essential for intranasal corticosteroids to be effective; your pharmacist or practice nurse can demonstrate proper use.

Sources: UK Kidney Association statement on race-neutral eGFR (2021); NICE NG203 CKD; NICE CKS Allergic rhinitis; NHS Hay fever page; EMC SmPC for fluticasone and mometasone nasal sprays.

When to Seek Medical Advice About Allergy Medication and CKD

Immediate medical attention is required if you experience signs of a severe allergic reaction (anaphylaxis), including difficulty breathing, swelling of the face, lips, tongue or throat, rapid pulse, dizziness, or widespread rash. Call 999 or attend A&E immediately, as anaphylaxis is a medical emergency regardless of kidney function.

You should contact your GP or renal specialist before starting any new allergy medication, including over-the-counter antihistamines, if you have been diagnosed with CKD. This is particularly important if your kidney function has changed since your last assessment, if you have stage 3b CKD or worse (eGFR below 45 mL/min/1.73m²), or if you are taking multiple medications that might interact. Your healthcare provider can review your current medication list, check for potential interactions, and recommend an appropriate option with suitable dosing. If you are on dialysis or have had a kidney transplant, always check with your renal team before starting new medications.

Seek prompt medical advice if you develop new or worsening symptoms whilst taking allergy medication, including increased drowsiness or confusion, difficulty urinating, irregular heartbeat, significant dizziness, or any symptoms suggesting declining kidney function such as reduced urine output, swelling in legs or ankles, or unexplained fatigue. These may indicate medication accumulation or adverse effects requiring dose adjustment or alternative treatment. For urgent advice that is not life-threatening, you can contact NHS 111.

Regular medication reviews with your GP or pharmacist are essential for people with CKD, ideally at least annually or whenever kidney function changes. During these reviews, all medications—including those for allergies—should be assessed for continued appropriateness, correct dosing, and potential alternatives. Keep an updated list of all medications, supplements, and herbal products you take, as some complementary therapies may affect kidney function or interact with prescribed medications. Your community pharmacist is an excellent resource for checking whether over-the-counter allergy products are suitable for your level of kidney function.

If you experience a suspected side effect from any allergy medication, you can report it via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk or through the Yellow Card app. Reporting helps improve the safety of medicines for everyone.

Sources: NHS anaphylaxis guidance; MHRA Yellow Card Scheme; NICE NG203 CKD.

Frequently Asked Questions